Clinical Trials Logo

Episodic Cluster Headache clinical trials

View clinical trials related to Episodic Cluster Headache.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02797951 Completed - Clinical trials for Chronic Cluster Headache

A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Start date: July 13, 2016
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).

NCT ID: NCT02397473 Completed - Clinical trials for Episodic Cluster Headache

A Study Of Galcanezumab In Participants With Episodic Cluster Headache

Start date: May 22, 2015
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as Galcanezumab in participants with episodic cluster headaches.

NCT ID: NCT00069082 Completed - Clinical trials for Episodic Cluster Headache

Intranasal Civamide for Episodic Cluster Headache

Start date: August 2003
Phase: Phase 3
Study type: Interventional

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

NCT ID: NCT00033839 Completed - Clinical trials for Episodic Cluster Headache

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Start date: January 2002
Phase: Phase 3
Study type: Interventional

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).